<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-pharmaceuticals-12-00147">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Constantinides</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Severin</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Gumpper</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Characterization of the PB2 Cap Binding Domain Accelerates Inhibitor Design</article-title>
  <source>Crystals</source>
  <year>2018</year>
  <volume>8</volume>
  <elocation-id>62</elocation-id>
  <pub-id pub-id-type="doi">10.3390/cryst8020062</pub-id>
 </element-citation>
</ref>
